Athersys
ATHX
#11270
Rank
A$1.24 M
Marketcap
A$0.02025
Share price
-33.50%
Change (1 day)
-98.93%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -A$62.62 Million

According to Athersys's latest financial reports the company's current earnings are A$0.08 Million. In 2022 the company made an earning of -A$0.12 Billion, an increase over its 2021 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$62.62 Million-45.8%
2022 -A$0.12 Billion-11.54%
2021 -A$0.14 Billion11.14%
2020 -A$0.12 Billion72.2%
2019 -A$68.24 Million77.29%
2018 -A$38.49 Million-22.91%
2017 -A$49.93 Million111.89%
2016 -A$23.57 Million-8.52%
2015 -A$25.76 Million-40.81%
2014 -A$43.53 Million18.62%
2013 -A$36.69 Million
2011 -A$20.68 Million19.71%
2010 -A$17.27 Million-26.28%
2009 -A$23.43 Million-18.21%
2008 -A$28.64 Million-8.28%
2007 -A$31.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.08 B-44,927.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.45 B-16,785.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.57 B-26,564.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.68 B-18,748.60%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$10.08 B-16,198.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.99 B-27,234.72%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
A$0.25 B-512.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.57 Billion 7,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.95 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA